CD4 T cells are important for immunity to tuberculosis as a result of they produce cytokines, together with interferon-γ. Whether or not CD4 T cells act as “helper” cells to advertise optimum CD8 T cell responses throughout Mycobacterium tuberculosis is unknown.
Utilizing two unbiased fashions, we present that CD4 T cell assist enhances CD8 effector features and prevents CD8 T cell exhaustion. We show synergy between CD4 and CD8 T cells in selling the survival of contaminated mice.
Purified helped, however not helpless, CD8 T cells effectively prohibit intracellular bacterial progress in vitro. Thus, CD4 T cell assist performs a vital function in producing protecting CD8 T cell responses towards M. tuberculosis an infection in vitro and in vivo.
We infer vaccines that elicit each CD4 and CD8 T cells are extra seemingly to achieve success than vaccines that elicit solely CD4 or CD8 T cells.

Latent Tuberculosis An infection Screening and Remedy in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Launch Assay Cohort

In 2017, the Korean authorities launched an unprecedentedly large-scaled latent tuberculosis an infection (LTBI) screening venture which lined greater than one million people in congregate settings.
A complete of 1,047,689 contributors of supply inhabitants (n = 2,336,157) underwent LTBI testing from 2017 to 2018. The general LTBI check uptake price throughout this venture was 44.8%. Staff in daycare facilities (83.5%) and kindergartens (78.9%) confirmed excessive participation price.
A complete of 1,012,206 people with legitimate outcomes of interferon-gamma launch assay (IGRA) have been chosen to represent the IGRA cohort. Many of the enrolled contributors within the IGRA cohort have been of their working age.
Roughly, three-quarters of complete enrolled inhabitants have been feminine. Investigating the LTBI prevalence, phases of LTBI care cascade, pure historical past of LTBI, efficacy of LTBI remedy and cost-effectiveness of LTBI screening are possible inside this IGRA cohort.

Building of a eukaryotic expression system with secure and secretory expression of mycobacterium tuberculosis 38 kDa protein

The 38 kDa protein is a serious antigen of mycobacterium tuberculosis and has been broadly utilized in TB serodiagnosis, on account of its extremely sensitivity and specificity. Right here we try to ascertain a manufacturing platform of recombinant 38 kDa protein in mammalian cells and to guage the potential worth of 38 kDa protein in TB serodiagnosis.
The 38 kDa gene is synthesized and cloned right into a lentiviral expressing vector. Recombinant lentiviral vector LV-CMV-38 kDa-eGFP was packaged, titered, after which transduced into HEK 293 T cells. Recombinant cell traces have been chosen by limiting dilution.
Supernatants have been collected and purified by HisTrapTM HP column. Western blot confirmed a molecular weight of approximate 38 kDa in cell supernatants as anticipated. ELISA assay confirmed the immunological specificity of the obtained protein within the presence of MTB-infected human serum samples.
In all, we now have obtained a secure cell line with long-term and sturdy expression of secretory MTB 38 kDa protein, which can present a promising candidate antigen for the event of TB serological analysis.

Interplay of host sample recognition receptors (PRRs) with Mycobacterium tuberculosis and Ayurvedic administration of tuberculosis: a systemic strategy

Tuberculosis (TB) an infectious illness brought on by Mycobacterium tuberculosis (Mtb), infects the lungs’ alveolar surfaces by the aerosol droplets. At this stage, the illness development might have many penalties, decided primarily by the reactions of the human immune system.
Nonetheless one strategy shall be to extra actively combine the immune system; particularly the sample recognition receptor (PRR) methods of the host, which notices pathogen-associated molecular patterns (PAMPs) of Mtb. A number of varieties of PRRs are concerned within the detection of Mtb together with Toll-like receptors (TLRs), C-type lectin receptors (CLRs),
Dendritic cell (DC) -specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), Mannose receptor (MR) and NOD-like receptors (NLRs) associated to inflammasome activation.
On this examine, we focus to assessment the Mtb pathophysiology and interplay of host PPRs with Mtb in addition to hostile drug results of anti-tuberculosis medicine (ATDs) and systematic TB remedy by way of Ayurvedic drugs.

6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis progress by alteration of tryptophan biosynthesis

A significant constraint in decreasing tuberculosis epidemic is the emergence of strains immune to a number of of clinically permitted antibiotics, which emphasizes the necessity of novel medicine with novel targets.
Genetic knockout strains of Mycobacterium tuberculosis (Mtb) have established that tryptophan (Trp) biosynthesis is crucial for the bacterium to outlive in vivo and trigger illness in animal fashions.
An anthranilate-like compound, 6-FABA, was beforehand proven to synergize with the host immune response to Mtb an infection in vivo. Herein, we current a category of anthranilate-like compounds endowed with good antimycobacterial exercise and low cytotoxicity.
We present how changing the carboxylic moiety with a hydrazide led to a big enchancment in each exercise and cytotoxicity relative to the guardian compound 6-FABA. A number of new benzohydrazides (compounds 20-31, 33, 34, 36, 38 and 39) confirmed good actions towards Mtb (0.625 ≤ MIC≤6.25 μM) and demonstrated no detectable cytotoxicity towards Vero cell assay (CC50 ≥ 1360 μM).
The goal preliminary research confirmed the speculation that this new class of compounds inhibits Trp biosynthesis. Taken collectively, these findings point out that fluorophenylbenzohydrazides symbolize good candidates to be assessed for drug discovery.

Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and goal Pik1

The pathogen Mycobacterium tuberculosis (Mtb) evades the innate immune system by interfering with autophagy and phagosomal maturation in macrophages, and, in consequence, small molecule stimulation of autophagy represents a host-directed therapeutics (HDTs) strategy for remedy of tuberculosis (TB).
Right here we present the marine pure product clionamines activate autophagy and inhibit Mtb survival in macrophages. A yeast chemical-genetics strategy recognized Pik1 as goal protein of the clionamines. Biotinylated clionamine B pulled down Pik1 from yeast cell lysates and a clionamine analog inhibited phosphatidyl 4-phosphate (PI4P) manufacturing in yeast Golgi membranes.
Chemical-genetic profiles of clionamines and cationic amphiphilic medicine (CADs) are intently associated, linking the clionamine mode of motion to co-localization with PI4P in a vesicular compartment.

Cancer Antigen 50 Antigen

VAng-Cr3877-50kU 50 kU
EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

A549 HCP Control Antigen

F237 50 ul
EUR 308.4
Description: A549 HCP Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Cancer Antigen 72-4 Antigen

VAng-Cr3878-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Antigen 85-A Antibody (HRP)

20-abx109227
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A Antibody (FITC)

20-abx107809
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A (Ag85A) Antibody

20-abx110661
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

A549 HCP Antigen Concentrate

F233G 200 ul
EUR 540
Description: A549 HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur.

Antigen 85-A Antibody (Biotin)

20-abx106397
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer Antigen 125 Antigen (Ascites Fluid)

VAng-Cr3870-10kU 10 kU
EUR 1132.8
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.

Cancer Antigen 125 Antigen (Human Adenocarcinoma)

VAng-Cr3868-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Human carcinoembryonic antigen (CEA) antigen

CEA15-N-100 100 ug
EUR 270

HCV NS4 1916-1947aa recombinant antigen

00156-V-01mg 0,1 mg
EUR 321
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS4 1916-1947aa recombinant antigen

00156-V-1000ug 1000 ug
EUR 1539
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen

00157-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen

00157-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2212-2313aa recombinant antigen

00158-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

HCV NS5 2212-2313aa recombinant antigen

00158-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

HCV NS4 1916-1947aa recombinant antigen.

00156-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen.

00157-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS5 2061-2302aa recombinant antigen.

Cancer Antigen CEA Antigen (Human Fluids)

VAng-Wyb8644-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL.

Cancer Antigen 19-9 Antigen (Liver Carcinoma)

VAng-Cr3873-10kU 10 kU
EUR 472.8
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

HCV core 2-119aa recombinant antigen

00150-V-01mg 0,1 mg
EUR 321
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

HCV core 2-119aa recombinant antigen

00150-V-1000ug 1000 ug
EUR 1539
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

Prostate Specific Antigen Std Grade Antigen

VAng-Cr3891-1mg 1 mg
EUR 604.8
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation.

Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%)

VAng-Cr3869-25kU 25 kU
EUR 967.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186.

M. Tuberculosis 85-A Antigen

DAGA-181 100 µg
EUR 868.8

HBV surface recombinant antigen HBsAg antigen

00123-V-01mg 0,1 mg
EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen

00123-V-1000ug 1000 ug
EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen

00124-V-01mg 0,1 mg
EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

HBV surface recombinant antigen HBsAg antigen

00124-V-1000ug 1000 ug
EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%)

VAng-Cr3875-25kU 25 kU
EUR 885.6
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Cancer Antigen AFP Antigen (Human Cord Blood)

VAng-Wyb8624-inquire inquire Ask for price
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL.

Cancer Antigen CA-125 Antigen (Human Fluids)

VAng-Wyb8639-inquire inquire Ask for price
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL.

Cancer Antigen 15-3 MUC 1 Antigen (Human Milk)

VAng-Cr3871-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Sperm Associated Antigen 11A (SPAG11A) Antibody

abx238139-100ug 100 ug
EUR 661.2

Sperm Associated Antigen 11A (SPAG11A) Antibody

20-abx115757
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Sperm Associated Antigen 11A (SPAG11A) Antibody

abx025940-400ul 400 ul
EUR 627.6

Sperm Associated Antigen 11A (SPAG11A) Antibody

abx025940-80l 80 µl
EUR 343.2

Sperm Associated Antigen 11A (SPAG11A) Antibody

20-abx124930
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

MPO Antigen

E61A00501 1mg
EUR 1230

HAV Antigen

E61H00101 1mg
EUR 733.2

HBS Antigen

E61H00301 1mg
EUR 374.4

HBS Antigen

E61H00302 1mg
EUR 374.4

HBe Antigen

E61H00501 1mg
EUR 463.2

HBc Antigen

E61H00701 1mg
EUR 463.2

AFP Antigen

E62C002 20ug
EUR 458.4

HCG Antigen

E62C004 100ug
EUR 458.4

CEA Antigen

E62C010 20ug
EUR 458.4

CK8 Antigen

E62C02001 20ug
EUR 458.4

CRP Antigen

E64C00501 1mg
EUR 840

CRP Antigen

E64C00502 1mg
EUR 840

CD9 Antigen

E6TA00101 0.1mg
EUR 411.6

BSA Antigen

IM112 1 ml
EUR 342
Description: BSA Antigen by Cygnus Technologies is available in Europe via Gentaur.

HSA Antigen

IM118 1 ml
EUR 342
Description: HSA Antigen by Cygnus Technologies is available in Europe via Gentaur.

CDV Antigen

VAng-Lsx0016-1mg 1 mg
EUR 1688.4
Description: Canine Distemper Virus Antigen from SL-29 cells.

Gastrointestinal Cancer Antigen (CA 19-9), antigen grade

CA1991-N-10 10 KU
EUR 634.8

Inactivated Coxsackievirus A16 Antigen

VAng-Lsx0079-1mL 1 mL
EUR 700.8
Description: Coxsackievirus A16, natural antigen.

S100 Antigen

E62B003 20ug
EUR 458.4

CA50 Antigen

E62C009 10KU
EUR 458.4

CK18 Antigen

E62C02101 20ug
EUR 458.4

CK20 Antigen

E62C02201 20ug
EUR 458.4

GP73 antigen

E62C02701 20ug
EUR 458.4

TP17 Antigen

E62H00701 100ug
EUR 458.4

TP47 Antigen

E62H00702 100ug
EUR 458.4

cTnI antigen

E64C00101 100ug
EUR 508.8

cTnI antigen

E64C00102 100ug
EUR 733.2

cTnC antigen

E64C01301a 20ug
EUR 411.6

sST2 antigen

E64C01501 20ug
EUR 411.6

PAPP Antigen

E64D00101 100ug
EUR 1425.6

PAPP Antigen

E64D00102 1mg
EUR 5910

CD63 Antigen

E6TA00102 0.1mg
EUR 411.6

CD81 Antigen

E6TA00103 0.1mg
EUR 411.6

Cancer Antigen CEA Antigen (Human Metastatic Liver)

VAng-Wyb8645-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL.

CA242 Antigen

E62C00601 50KU
EUR 2078.4

CA242 Antigen

E62C00602 10KU
EUR 458.4

CA199 Antigen

E62C007 10KU
EUR 458.4

CA199 Antigen

E62C00701 50KU
EUR 1180.8

CA199 Antigen

E62C00702 50KU
EUR 1620

CA125 Antigen

E62C011 10KU
EUR 458.4

CA153 Antigen

E62C012 10KU
EUR 458.4

EpCAM Antigen

E64B00107 0.1mg
EUR 411.6

HSP70 Antigen

E6TA00104 0.1mg
EUR 411.6

CD133 Antigen

E6TA00105 0.1mg
EUR 411.6

CD32a Antigen

E6TA00106 0.1mg
EUR 411.6

Cancer Antigen CA-125 Antigen (Human Adenocarcinoma)

VAng-Wyb8642-inquire inquire Ask for price
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL.

S100BB Antigen

E62B00201 20ug
EUR 458.4

S100BB Antigen

E62B00202 20ug
EUR 458.4

Giardia Trophozoite Recombinant antigen antigen 34 kDa

00321-V-01mg 0,1 mg
EUR 321
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280

Giardia Trophozoite Recombinant antigen antigen 34 kDa

00321-V-1000ug 1000 ug
EUR 1539
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (High purity)

VAng-Cr3874-25kU 25 kU
EUR 1033.2
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma.

S100A1B Antigen

E62B00101 20ug
EUR 458.4

S100A1B Antigen

E62B00102 20ug
EUR 458.4

Insulin Antigen

E64I001 1mg
EUR 418.8

Insulin Antigen

IM121 1 ml
EUR 342
Description: Insulin Antigen by Cygnus Technologies is available in Europe via Gentaur.

Ferritin Antigen

E62C013 100ug
EUR 458.4

Ferritin Antigen

E62C01304 100ug
EUR 458.4

Copeptin antigen

E64C01601 100ug
EUR 411.6

Cancer Antigen AFP Antigen (Human hepatocellular carcinoma)

VAng-Wyb8625-inquire inquire Ask for price
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL.

HHV-4 recombinant EA antigen. Region: 306-390aa

00213-V-100ugvial 100ug/vial
EUR 150
Description: HHV-4 recombinant EA antigen. Region: 306-390aa

Rotavirus Antigen

DAGA-258 1 ml dry ice
EUR 873.6

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit

E02C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit

E02C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit

E02C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit

E07C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit

E07C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit

E08C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit

E08C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit

E08C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit

E07C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid)

VAng-Cr3872-10kU 10 kU
EUR 1363.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid.

GPA33 Antibody / Cell surface A33 antigen

F55008-0.08ML 0.08 ml
EUR 140.25
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling.

GPA33 Antibody / Cell surface A33 antigen

F55008-0.4ML 0.4 ml
EUR 322.15
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling.

HHV-4 recombinant p18 antigen Region: 1-119aa

00211-V-100ugvial 100ug/vial
EUR 150
Description: HHV-4 recombinant p18 antigen Region: 1-119aa

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit

E06C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit

E06C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit

E06C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC800883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC800883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC810883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC810883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC940883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC940883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC700883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF770 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC700883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF770 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC880883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF488A conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC880883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF488A conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC050883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405M conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC050883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405M conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC040883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405S conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC040883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF405S conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC400883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF640R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNC400883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF640R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCB0883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Biotin conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCB0883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Biotin conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCAP0883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCAP0883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCA0883-250 250uL
EUR 459.6
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), APC conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCR0883-250 250uL
EUR 459.6
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), RPE conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCP0883-250 250uL
EUR 459.6
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), PerCP conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNUM0883-50 50uL
EUR 474
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), 1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCH0883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNCH0883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNUB0883-100 100uL
EUR 250.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Concentration: 0.2mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody

BNUB0883-500 500uL
EUR 549.6
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), Concentration: 0.2mg/mL
Small interfering RNA (siRNA) knockdown of PI4KB, a human homolog of Pik1, inhibited the survival of Mtb in macrophages, figuring out PI4KB as an unexploited molecular goal for efforts to develop HDT medicine for remedy of TB.

LEAVE A REPLY

Please enter your comment!
Please enter your name here